Although one study reported that single nucleotide polymorphism rs2278034 in ACK1 affects the outcomes of IFN-α therapy in chronic hepatitis C patients (Fujimoto et al., 2011), the precise mechanism underlying the antiviral activity of ACK1 had not been elucidated. The gene discussed is TNK2; the disease is chronic hepatitis C virus infection.